Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/158950
Full metadata record
DC FieldValueLanguage
dc.contributor.authorde la Torre, Beatriz G.-
dc.contributor.authorAlbericio Palomera, Fernando-
dc.date.accessioned2020-05-06T15:29:41Z-
dc.date.available2020-05-06T15:29:41Z-
dc.date.issued2017-02-27-
dc.identifier.issn1420-3049-
dc.identifier.urihttp://hdl.handle.net/2445/158950-
dc.description.abstractThis is an analysis from a chemical point of view of the 22 drugs accepted by the FDA during 2016. The different drugs from the 2016 "harvest" have been classified according to their chemical structure: antibodies; TIDES (oligonucleotides and peptides); amino acids and natural products; drug combination; and small molecules.-
dc.format.extent6 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/molecules22030368-
dc.relation.ispartofMolecules, 2017, vol. 22, num. 3, p. 368-
dc.relation.urihttps://doi.org/10.3390/molecules22030368-
dc.rightscc-by (c) de la Torre, Beatriz G. et al., 2017-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Química Inorgànica i Orgànica)-
dc.subject.classificationDisseny de medicaments-
dc.subject.classificationPèptids-
dc.subject.classificationFarmacologia-
dc.subject.otherDrug design-
dc.subject.otherPeptides-
dc.subject.otherPharmacology-
dc.titleThe Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecules-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec681089-
dc.date.updated2020-05-06T15:29:42Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid28264468-
Appears in Collections:Articles publicats en revistes (Química Inorgànica i Orgànica)

Files in This Item:
File Description SizeFormat 
681089.pdf1.45 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons